Article ID Journal Published Year Pages File Type
9257546 Critical Reviews in Oncology/Hematology 2005 7 Pages PDF
Abstract
Our results demonstrated that patient age and related IL-2 dose reduction do not impair the efficacy of sc-IL-2 plus sc-INF-2a based outpatient immunochemotherapy in metastastic renal carcinoma.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Hematology
Preview
Age does not impair the efficacy of immunochemotherapy in patients with metastatic renal carcinoma
Authors
, , ,